Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History $1.05 +0.02 (+1.94%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.03 -0.02 (-1.43%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enlivex Therapeutics Stock Price Performance The Enlivex Therapeutics (ENLV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 14.63%, with a year-to-date return of -10.26%. In the past month, the stock has decreased 8.06%, reflecting recent market activity. As of the latest close, Enlivex Therapeutics traded at $1.05 with a market cap of $24.83 million and volume of 887,884 shares. Five years ago, the stock traded at $4.78, representing a 78.03% decrease over that period. At the time, it had a market cap of $65.93 million and a volume of 109,781 shares. Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-8.06%3 Month Performance+7.69%Year-To-Date Performance-10.26%1 Year Performance-14.63%5 Year Performance-78.03% ENLV Stock Chart for Sunday, August, 24, 2025 ENLV Chart by TradingView Enlivex Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$1.03$1.05+1.94%$1.05$0.98887,884 shs$24.83 million08/21/2025$1.10$1.03-6.36%$1.12$1.01934,986 shs$24.36 million08/20/2025$1.05$1.10+4.76%$1.15$1.03878,547 shs$26.02 million08/19/2025$1.25$1.05-16.00%$1.24$1.022.91 million shs$24.83 million08/18/2025$1.82$1.25-31.32%$1.75$1.2210.43 million shs$29.56 million08/15/2025$1.78$1.82+2.25%$2.10$1.762.24 million shs$43.04 million08/14/2025$1.56$1.78+14.10%$1.84$1.55922,024 shs$42.10 million08/13/2025$1.57$1.56-0.64%$1.78$1.501.03 million shs$36.90 million08/12/2025$1.47$1.57+6.80%$1.64$1.47504,142 shs$37.13 million08/11/2025$1.43$1.47+2.80%$1.58$1.43466,541 shs$34.77 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$1.35$1.43+5.93%$1.49$1.35245,292 shs$33.82 million08/07/2025$1.35$1.35$1.39$1.32199,624 shs$31.93 million08/06/2025$1.39$1.35-2.88%$1.40$1.31325,651 shs$31.93 million08/05/2025$1.48$1.39-6.08%$1.53$1.34523,499 shs$32.87 million08/04/2025$1.45$1.48+2.07%$1.66$1.47819,515 shs$35.00 million08/01/2025$1.49$1.45-2.68%$1.52$1.41250,283 shs$34.29 million07/31/2025$1.54$1.49-3.25%$1.60$1.48307,709 shs$35.24 million07/30/2025$1.42$1.54+8.45%$1.66$1.44996,051 shs$36.42 million07/29/2025$1.26$1.42+12.70%$1.44$1.28668,799 shs$33.58 million07/28/2025$1.12$1.26+12.30%$1.29$1.161.05 million shs$29.80 million07/25/2025$1.14$1.12-1.75%$1.18$1.1239,288 shs$26.54 million07/24/2025$1.17$1.14-2.39%$1.19$1.1355,628 shs$27.01 million07/23/2025$1.18$1.17-0.85%$1.19$1.1697,368 shs$27.67 million Related Companies SLS Stock Chart ENTA Stock Chart LFVN Stock Chart CYBN Stock Chart ACTU Stock Chart NKTX Stock Chart NVCT Stock Chart BIOA Stock Chart GLSI Stock Chart CRDF Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access